JPWO2019191327A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019191327A5
JPWO2019191327A5 JP2020552805A JP2020552805A JPWO2019191327A5 JP WO2019191327 A5 JPWO2019191327 A5 JP WO2019191327A5 JP 2020552805 A JP2020552805 A JP 2020552805A JP 2020552805 A JP2020552805 A JP 2020552805A JP WO2019191327 A5 JPWO2019191327 A5 JP WO2019191327A5
Authority
JP
Japan
Prior art keywords
alkylene
alkyl
haloalkyl
alkoxy
conr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020552805A
Other languages
English (en)
Japanese (ja)
Other versions
JP7346439B2 (ja
JP2021519776A (ja
JP2021519776A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/024426 external-priority patent/WO2019191327A1/en
Publication of JP2021519776A publication Critical patent/JP2021519776A/ja
Publication of JPWO2019191327A5 publication Critical patent/JPWO2019191327A5/ja
Publication of JP2021519776A5 publication Critical patent/JP2021519776A5/ja
Priority to JP2023144744A priority Critical patent/JP2023171752A/ja
Application granted granted Critical
Publication of JP7346439B2 publication Critical patent/JP7346439B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020552805A 2018-03-27 2019-03-27 Ox2r化合物 Active JP7346439B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023144744A JP2023171752A (ja) 2018-03-27 2023-09-06 Ox2r化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862648933P 2018-03-27 2018-03-27
US62/648,933 2018-03-27
PCT/US2019/024426 WO2019191327A1 (en) 2018-03-27 2019-03-27 Ox2r compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023144744A Division JP2023171752A (ja) 2018-03-27 2023-09-06 Ox2r化合物

Publications (4)

Publication Number Publication Date
JP2021519776A JP2021519776A (ja) 2021-08-12
JPWO2019191327A5 true JPWO2019191327A5 (https=) 2022-04-01
JP2021519776A5 JP2021519776A5 (https=) 2022-04-01
JP7346439B2 JP7346439B2 (ja) 2023-09-19

Family

ID=68060742

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020552805A Active JP7346439B2 (ja) 2018-03-27 2019-03-27 Ox2r化合物
JP2023144744A Pending JP2023171752A (ja) 2018-03-27 2023-09-06 Ox2r化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023144744A Pending JP2023171752A (ja) 2018-03-27 2023-09-06 Ox2r化合物

Country Status (13)

Country Link
US (4) US11472813B2 (https=)
EP (1) EP3773566A4 (https=)
JP (2) JP7346439B2 (https=)
KR (1) KR20210010443A (https=)
CN (1) CN112165940A (https=)
AU (1) AU2019243141A1 (https=)
BR (1) BR112020019818A2 (https=)
CA (1) CA3095451C (https=)
CO (1) CO2020013492A2 (https=)
IL (1) IL277651A (https=)
MX (1) MX2020010155A (https=)
SG (1) SG11202009615UA (https=)
WO (1) WO2019191327A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112165940A (zh) * 2018-03-27 2021-01-01 德克萨斯州立大学董事会 Ox2r化合物
WO2021061801A1 (en) * 2019-09-24 2021-04-01 Icahn School Of Medicine At Mt. Sinai Bicyclic inhibitors of cbx chromodomains
EP4065585B1 (en) 2019-11-25 2025-08-20 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
US12006330B2 (en) 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment
US11760747B2 (en) 2020-12-21 2023-09-19 Alkermes, Inc. Substituted piperidino compounds and related methods of treatment
US20240174605A1 (en) * 2021-03-03 2024-05-30 Research Triangle Institute Arylsulfonamides as orexin receptor agonists
KR20240026483A (ko) * 2021-06-25 2024-02-28 재즈 파마슈티칼즈 아일랜드 리미티드 술폰아미드 오렉신 수용체 효능제 및 그의 용도
WO2025124698A1 (en) 2023-12-12 2025-06-19 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators
TW202542165A (zh) 2023-12-19 2025-11-01 瑞士商愛杜西亞製藥有限公司 大環食慾素激動劑
WO2025224168A1 (en) 2024-04-24 2025-10-30 Idorsia Pharmaceuticals Ltd Aryl sulfone and sulfanone derivatives as orexin receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004016A (en) * 1975-08-11 1977-01-18 E. R. Squibb & Sons, Inc. Amino-benzimidazole derivatives
US6521623B1 (en) * 2000-09-19 2003-02-18 Boehringer Ingelheim Pharma Kg N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
US7842817B2 (en) * 2005-01-11 2010-11-30 Neurosearch A/S 2-amino benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
US8871794B2 (en) * 2008-06-04 2014-10-28 Board Of Regents, The University Of Texas System Small-molecule agonists for type-2 orexin receptor
US8258163B2 (en) * 2008-06-04 2012-09-04 Board Of Regents, The University Of Texas System Small-molecule agonists for type-2 orexin receptor
US8633233B2 (en) * 2008-08-06 2014-01-21 Hydra Biosciences, Inc. Methods and compositions for treating anxiety
EP2364313B1 (en) * 2008-09-09 2014-01-08 Boehringer Ingelheim International GmbH Aza-benzimidazolone chymase inhibitors
WO2013068592A1 (en) * 2011-11-10 2013-05-16 Fondation Jerome Lejeune Inhibitors of cystathionine beta synthase to reduce the neurotoxic overproduction of endogenous hydrogen sulfide
MX2014014657A (es) * 2012-06-01 2015-08-10 Nogra Pharma Ltd Heterociclos bicíclicos capaces de modular las respuestas de los linfocitos t, y métodos de uso de los mismos.
CN112165940A (zh) * 2018-03-27 2021-01-01 德克萨斯州立大学董事会 Ox2r化合物

Similar Documents

Publication Publication Date Title
JP2021519776A5 (https=)
JPWO2019191327A5 (https=)
JPWO2021092115A5 (https=)
JP2021508686A5 (https=)
JP2020514334A5 (https=)
ES2216527T3 (es) Nuevo derivado (iii) de acido 3-aril-2-hidroxipropionico.
JP2010528089A5 (https=)
RU2014153800A (ru) Соединения 5-азаиндазола и способы их применения
JP2010501585A5 (https=)
JP2004502670A5 (https=)
JPWO2020106640A5 (https=)
JP2006523234A5 (https=)
JPWO2020123827A5 (https=)
BR112020025701A2 (pt) Processo de produção e intermediários para um composto de pirrolo[2,3-d]pirimidina e seu uso
JPWO2022251502A5 (https=)
JP2009501234A5 (https=)
JPWO2020060915A5 (https=)
JPWO2021222404A5 (https=)
JPWO2023016434A5 (https=)
JP2025514786A5 (https=)
JP2005539014A5 (https=)
JP2009525970A5 (https=)
JP2006515319A5 (https=)
JP2021505537A5 (https=)
JP2013544880A5 (https=)